Biotech
PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 10/04/12 -- The Medicines Company (NASDAQ: MDCO) today announced that it has voluntarily discontinued its Phase 2b dose-ranging study of MDCO-2010, a serine protease ...
PORT HUENEME, CA: PORT HUENEME, CA -- (Marketwire) -- 10/04/12 -- (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is very pleased to announce the filing of a US Letters Patent Application directed to protectin ...
COLUMBIA, MD and TORONTO: COLUMBIA, MD and TORONTO -- (Marketwire) -- 10/04/12 -- Medifocus Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce it will attend and has reserved booths at two upcoming Regional Section ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 10/04/12 -- Zenmark announced today their role in the development of the brand name REVESTIVE (teduglutide), a new therapy for Short Bowel Syndrome (SBS). "P ...
CAMBRIDGE, MA: Jeff Behrens Appointed CEO; Corporate Headquarters Moved to Cambridge, MA ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/04/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...
MANCHESTER, NH: MANCHESTER, NH -- (Marketwire) -- 10/04/12 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to ...
GHENT, BELGIUM: GHENT, BELGIUM -- (Marketwire) -- 10/04/12 --Results Will Be Discussed During a Webcast Presentation Today at 15h CET, 9 am EST
to register, call number +32 (0)2 620 01 38[EURONEXT BRUSSELS: ABLX] to ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 10/03/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN:US74154B2034) ("Prima," the "Company") today released its quarterly Shareholder N ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/03/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) reports that, subject to TSX Venture Exchange approval, the amount to be rai ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 10/03/12 -- Theratechnologies Inc. (TSX: TH)(NASDAQ: THER) (Theratechnologies) announced today that it will issue its financial results for the third quarter ende ...
WASHINGTON, DC: Agenda to Include Interactive Panels and Case Studies Featuring Key Opinion Leaders ...
SAN DIEGO, CA: Nexus Trial to Study Effects of Anti-S1P Monoclonal Antibody in Wet-AMD Patients ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/03/12 -- Med BioGene Inc. (TSX VENTURE: MBI) today provided an update regarding the commercialization of LungExpress Dx and ongoing litigation with ...
IRVINE, CA: IRVINE, CA -- (Marketwire) -- 10/03/12 -- Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam® Cold Remedy, and the founding President of Itonis Pharmaceuticals, ar ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 10/03/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, received notice from the U.S. Department of Defense (DoD) tha ...
CAMBRIDGE, MA: Eteplirsen Results in an Increase in Novel Dystrophin to 47% of Normal After 48 Weeks of Treatment; Eteplirsen 50mg/kg Weekly Demonstrates Continued Clinical Benefit of 89.4 Meters in 6-Minute Walk Te ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 10/03/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...
EDMONTON, ALBERTA, CANADA: EDMONTON, ALBERTA, CANADA -- (Marketwire) -- 10/02/12 -- Ceapro Inc. (TSX VENTURE: CZO) wishes to inform its shareholders that it has terminated its month to month contract with Renmark Financial Co ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 10/02/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today it will hold a conference call at 8:00 a.m. E ...
